Pura Vida Investments’s Standard BioTools LAB Stock Holding History

Pura Vida Investments’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-253,132	Closed	-$278K	–	220
2022 Q3	$278K	Sell	253,132 -596,868	-70%	-$902K	0.02%	180
2022 Q2	$1.36M	Hold	850,000	–	–	0.08%	152
2022 Q1	$3.05M	Buy	+850,000	New	+$2.94M	0.1%	143
2020 Q4	–	Sell	-812,757	Closed	-$6.04M	–	206
2020 Q3	$6.04M	Sell	812,757 -31,543	-4%	-$218K	0.31%	64
2020 Q2	$3.39M	Buy	+844,300	New	+$2.94M	0.33%	71
2020 Q1	–	Sell	-1,090,830	Closed	-$3.8M	–	115
2019 Q4	$3.8M	Buy	1,090,830 +590,830	+118%	+$2.08M	0.33%	70
2019 Q3	$2.31M	Buy	500,000 +260,000	+108%	+$2.05M	0.4%	62
2019 Q2	$2.96M	Sell	240,000 -180,000	-43%	-$2.29M	0.45%	68
2019 Q1	$5.58M	Sell	420,000 -258,596	-38%	-$2.73M	0.79%	41
2018 Q4	$5.85M	Buy	678,596 +453,596	+202%	+$3.53M	1.17%	17
2018 Q3	$1.69M	Buy	+225,000	New	+$1.6M	0.35%	70
2016 Q2	–	Sell	-125,000	Closed	-$1.01M	–	84
2016 Q1	$1.01M	Buy	+125,000	New	+$902K	0.46%	57

Other funds holding LAB

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

ICM

Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JCP

Jennifer C. Price $75.5M AUM 6.25% 1-Year Est. Return

Pura Vida Investments's LAB Position: Q4 2022 in Review

Pura Vida Investments sold out of Standard BioTools (LAB) in Q4 2022, closing a stake of 253,132 shares — an estimated $278K sold.

Pura Vida Investments first reported a position in LAB in Q1 2016 and held it in 12 quarters. The position peaked at $6.04M in Q3 2020. 68 funds tracked by Wall St. Rank hold LAB as of Q4 2022.

Pura Vida Investments reported no remaining Standard BioTools position as of Q4 2022 after selling out during the quarter.
Pura Vida Investments sold 253,132 Standard BioTools shares in Q4 2022, an estimated $278K.
Pura Vida Investments first reported a position in Standard BioTools in Q1 2016 and held it in 12 quarters.
Pura Vida Investments's Standard BioTools position peaked at $6.04M in Q3 2020.
68 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2022.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.